CARGO Therapeutics (NASDAQ:CRGX) Now Covered by Analysts at Truist Financial

Truist Financial began coverage on shares of CARGO Therapeutics (NASDAQ:CRGX – Free Report) in a research report report published on Tuesday morning, MarketBeat Ratings reports. The brokerage issued a buy rating and a $34.00 price objective on the stock. A number of other equities analysts have also recently issued reports on CRGX. Jefferies Financial Group […]

Leave a Reply

Your email address will not be published.

Previous post BMO Capital Markets Downgrades Sibanye Stillwater (NYSE:SBSW) to Market Perform
Next post Albert Soleiman Buys 332 Shares of CMC Markets plc (LON:CMCX) Stock